Search
This editorial by Brandon Macsata was published in The International Business Times on November 1, 2020. Macsata has been living with HIV since 2002, and serves as the CEO of the ADAP Advocacy Association, an organization that promotes the AIDS Drug Assistance Program and works to improve access to care.
Read More
With the recent report that police in Maui, Hawaii seized 400 counterfeit oxycodone pills made with fentanyl on October 2, 2020, the United States has reached a sobering milestone: public sources have reported about fake pills made with fentanyl in all 50 states.
Read More
In PSM’s round-up this week: news about state drug importation, COVID-19 fraud, deadly workout supplements and counterfeit pills made with fentanyl.
Read More
In this October 23, 2020 editorial, which was published in the The American Journal of Managed Care, Michael Abrams explains why drug importation will not save patients money. Abrams is the co-founder and managing partner of Numerof & Associates.
Read More
A summary briefing of 2020’s major cases, worrying trends and a deep dive into drug supply chain policy issues.
Read More
In PSM’s round-up this week: new reports about counterfeit medicine, drug supply chain regulation and phishing scams; FDA warnings about dangerous supplements; a life sentence for fake pill kingpin Aaron Shamo; and more.
Read MoreINTRODUCTION Just as the coronavirus mutates to survive and thrive, so to do the purveyors of counterfeit medicines – with their high-speed “host” being the digi-tization of patient care. The future is now. So, how do we balance moving forward with user-friendly digitization, telemedicine and virtual healthcare delivery while simultaneously recognizing the unintended consequences of the innovative criminal mind? The…
Read MoreIn this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.
Read More
In PSM’s round-up this week: Policy truths about drug importation, prosecutions for fake COVID-19 treatments and financial fraud, and another week in counterfeit pills.
Read More
In the first seven months of 2020, the Arizona Department of Health Services reported over 2,700 newly suspected opioid overdose deaths in Arizona. What makes this figure more startling is that there were just over 3,800 suspected opioid deaths in the preceding 30 months. The problem is escalating, and rapidly.
Read More